BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19887237)

  • 1. [Apocrine lesions in breast pathology].
    Suciu V; Menet E; Guinebretière JM; Trassard M; Vielh P
    Ann Pathol; 2009 Nov; 29 Spec No 1():S112-3. PubMed ID: 19887237
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of myoepithelium in apocrine glands of the breast does not necessarily imply malignancy.
    Cserni G
    Histopathology; 2008 Jan; 52(2):253-5. PubMed ID: 18184276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Needle aspiration cytologic examinations of dysplastic diseases of the breast (mastopathy, adenosis, ductasia and gynecomastia].
    Degrell I
    Pathologe; 1982 Jul; 3(4):198-202. PubMed ID: 6125937
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical apocrine metaplasia: a diagnostic pitfall in fine needle aspiration cytology of the breast.
    Ng WK; Kong JH; Wong WW
    Acta Cytol; 2003; 47(4):698-701. PubMed ID: 12920771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Architectural disorganization and large cells].
    Algros MP; Arnould L; Felix S; Le Bail K; Schaal JP; Carbillet JP; Kantelip B
    Ann Pathol; 2003 Feb; 23(1):67-8. PubMed ID: 12743504
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast MRI-detected cystic apocrine metaplasia: imaging features with microvessel analysis and histologic correlation.
    diFlorio-Alexander RM; Marotti JD; Bond JS; Schwab MC; Memoli VA; Wells WA; Poplack SP
    AJR Am J Roentgenol; 2015 Jan; 204(1):211-8. PubMed ID: 25539259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uneven distribution and significant concentration of apocrine metaplasia in lower breast quadrants.
    Benigni G; Squartini F
    Tumori; 1986 Apr; 72(2):179-82. PubMed ID: 3705191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrocystic disease in the male breast.
    Banik S; Hale R
    Histopathology; 1988 Feb; 12(2):214-6. PubMed ID: 3366438
    [No Abstract]   [Full Text] [Related]  

  • 12. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 15. Apocrine adenoma of the breast.
    Cashell AW
    W V Med J; 2008; 104(2):16-9. PubMed ID: 18491794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclin D-1 protein over-expression is not associated with gene amplification in benign and atypical apocrine lesions of the breast.
    Elayat G; Selim AG; Gorman P; Tomlinson I; Wells CA
    Pathol Res Pract; 2011 Feb; 207(2):75-8. PubMed ID: 21159451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
    Visscher DW
    Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic pitfalls in mammary pathology. Case 2. Atypical duct hyperplasia within columnar cell changes with atypia].
    Vincent-Salomon A
    Ann Pathol; 2009 Jun; 29(3):194-8. PubMed ID: 19619825
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
    Selim AG; El-Ayat G; Wells CA
    Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.